Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis
Clinical trial NCT02804191 · COMPLETED
Trial details
- NCT number
- NCT02804191
- Sponsor
- Ocuwize LTD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2019-06-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.